IRIS
SILVESTRO, MARCELLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.269
NA - Nord America 1.778
AS - Asia 1.563
SA - Sud America 204
Continente sconosciuto - Info sul continente non disponibili 102
AF - Africa 17
OC - Oceania 7
Totale 7.940
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.255
US - Stati Uniti d'America 1.698
SG - Singapore 600
IT - Italia 475
CN - Cina 312
VN - Vietnam 252
IE - Irlanda 206
HK - Hong Kong 178
BR - Brasile 166
DE - Germania 90
GB - Regno Unito 70
KR - Corea 57
JP - Giappone 53
CA - Canada 46
IN - India 43
FI - Finlandia 27
SE - Svezia 19
AT - Austria 18
GR - Grecia 16
AR - Argentina 15
CZ - Repubblica Ceca 14
UA - Ucraina 12
ES - Italia 11
NL - Olanda 11
BE - Belgio 10
CR - Costa Rica 10
MX - Messico 10
BD - Bangladesh 9
FR - Francia 9
AU - Australia 6
CH - Svizzera 6
PK - Pakistan 6
TR - Turchia 6
CO - Colombia 5
DZ - Algeria 5
EC - Ecuador 5
GT - Guatemala 5
ID - Indonesia 5
IQ - Iraq 5
PL - Polonia 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
IR - Iran 4
MY - Malesia 4
PH - Filippine 4
PT - Portogallo 4
PY - Paraguay 4
UZ - Uzbekistan 4
PE - Perù 3
RO - Romania 3
ZA - Sudafrica 3
CL - Cile 2
KE - Kenya 2
LV - Lettonia 2
MA - Marocco 2
MT - Malta 2
NP - Nepal 2
SA - Arabia Saudita 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
HT - Haiti 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
NI - Nicaragua 1
NR - Nauru 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.839
Salva come PNG Salva come JPEG
Città #
Moscow 1.235
San Jose 329
Singapore 303
Ashburn 222
Dublin 206
Hong Kong 174
Council Bluffs 163
Santa Clara 157
Naples 89
Ho Chi Minh City 77
Hanoi 68
Beijing 60
Seoul 57
Chandler 56
Milan 53
Hefei 41
Los Angeles 41
Munich 38
Dallas 28
Princeton 27
Jacksonville 26
New York 26
Roxbury 26
Bremen 24
Da Nang 20
Bengaluru 19
The Dalles 19
Medford 18
Miano 16
Rome 15
Helsinki 14
São Paulo 14
Aversa 13
Brno 13
Montreal 12
Bologna 11
Des Moines 11
Atlanta 10
Haiphong 10
Turku 10
Vienna 10
Bến Tre 9
Caserta 9
Orem 9
Reggio Emilia 9
Tokyo 9
Cambridge 8
Toronto 8
Viterbo 8
Belo Horizonte 7
Boardman 7
Brooklyn 7
Hasselt 7
Kochi 7
London 7
Nanjing 7
Napoli 7
Nuremberg 7
Phoenix 7
San Francisco 7
San José 7
Stockholm 7
Denver 6
Frankfurt am Main 6
Hillsboro 6
Houston 6
Amsterdam 5
Bari 5
Biên Hòa 5
Chennai 5
Chicago 5
Falkenstein 5
Guarulhos 5
Hebei 5
Mexico City 5
Norwalk 5
Wilmington 5
Avella 4
Boston 4
Bắc Ninh 4
Cagliari 4
Curitiba 4
Dhaka 4
Florence 4
Guangzhou 4
Guatemala City 4
Hangzhou 4
Hải Dương 4
Newark 4
Ninh Bình 4
Sacramento 4
Salerno 4
Shenyang 4
Tashkent 4
Warsaw 4
Afragola 3
Ann Arbor 3
Brussels 3
Buffalo 3
Can Tho 3
Totale 4.087
Salva come PNG Salva come JPEG
Nome #
A subjective cognitive impairments scale for migraine attacks: validation of the Italian version of the MIG-SCOG 192
Resting state fMRI analysis of pseudobulbar affect in Amyotrophic Lateral Sclerosis (ALS): motor dysfunction of emotional expression 186
Telemedicine application to headache: a critical review 181
Cluster headache pathophysiology: What we have learned from advanced neuroimaging 176
Cognitive, behavioral, and brain functional connectivity correlates of fatigue in amyotrophic lateral sclerosis 170
Cognitive and morphometric features of mild cognitive impairment reversion in early patients with Parkinson's disease 169
Advanced visual network and cerebellar hyperresponsiveness to trigeminal nociception in migraine with aura 165
Can Craniometry Play a Role in Cluster Headache Diagnosis? A Pilot Exploratory TC-3D Based Study 165
Cognitive Networks Disarrangement in Patients With Migraine Predicts Cutaneous Allodynia 159
Resting-state network connectivity changes in drug-naive Parkinson's disease patients with probable REM sleep behavior disorder 156
Infodemiology of cluster headache seasonality: A proof of concept by a Google Trends analysis 154
Brain neurovascular coupling in amyotrophic lateral sclerosis: Correlations with disease progression and cognitive impairment 151
Arterial spin labeling MRI applied to migraine: current insights and future perspectives 148
Advances in migraine neuroimaging and clinical utility: from the MRI to the bedside 147
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail 138
Effectiveness and safety of CGRP monoclonal antibodies in migraine related to mitochondrial diseases in patients with NARP and PEO syndromes 136
Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience 136
Coping Strategies in Migraine without Aura: A Cross-Sectional Study 134
Disconnectome of the migraine brain: a "connectopathy" model 128
Reduced neurovascular coupling of the visual network in migraine patients with aura as revealed with arterial spin labeling MRI: is there a demand-supply mismatch behind the scenes? 127
Resting-State Functional MRI Approaches to Parkinsonisms and Related Dementia 124
Emerging drugs for the preventive treatment of migraine: a review of CGRP monoclonal antibodies and gepants trials 123
Readability Analysis of Online Headache and Migraine Information 123
The "Cluster-SUNCT Syndrome": The Lumper-Splitter Problem 121
Galcanezumab effect on "whole pain burden" and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience 120
Screening of visuospatial abilities in amyotrophic lateral sclerosis (ALS): a pilot study using the battery for visuospatial abilities (BVA) 119
Psychological Support for Family Caregivers of Patients With Amyotrophic Lateral Sclerosis at the Time of the Coronavirus Disease 2019 Pandemic: A Pilot Study Using a Telemedicine Approach 117
Dihydroergotamine mesylate nasal spray: an acute treatment option for migraine in adults 117
Intrinsic brain functional connectivity predicts treatment-related motor complications in early Parkinson’s disease patients 114
Validation of new diagnostic criteria for fatigue in patients with Parkinson disease 113
The conundrum of relationship between pain and visual pathway in migraine with aura 113
Headache Worsening after COVID-19 Vaccination: An Online Questionnaire-Based Study on 841 Patients with Migraine 108
SUNCT-Induced Jaw Opening: A Rare Trigeminal Autonomic Phenotype 106
Perceived ease-of-usability and local tolerability using CGRP monoclonal antibody autoinjectors vs. syringes: an online questionnaire-based study in patients with migraine 104
A case of rapidly progressive juvenile amyotrophic lateral sclerosis associated with a pathogenetic heterozygous de novo variant in the FUS gene 103
The "Ram's Horns Sign": A Case Report of an Unusual Side Effect of OnabotulinumtoxinA in a Chronic Migraine Patient 101
Migraine in the Time of COVID-19 101
Migraine as a Cortical Brain Disorder 101
Erenumab Efficacy on Comorbid Cluster Headache in Patients With Migraine: A Real-World Case Series 100
Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience 98
Functional neuroimaging biomarkers in migraine: diagnostic, prognostic and therapeutic implications 96
Recent Insights in Migraine With Aura: A Narrative Review of Advanced Neuroimaging 93
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients 92
"Forced Normalization": Could It Occur Also in Migraine Patients? 92
No additional benefit with detoxification strategies: A real world experience in 200 patients with chronic migraine and either simple or complex MOH treated with CGRP monoclonal antibodies 91
Functional connectivity changes in complex migraine aura: beyond the visual network 89
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study 87
Evidence-based guidelines for the pharmacological treatment of migraine, summary version 84
Pain Perception and Migraine 83
Additive Interaction Between Onabotulinumtoxin-A and Erenumab in Patients With Refractory Migraine 82
Shedding light on migraine with aura: the clarifying role of advanced neuroimaging investigations 82
Evidence-based guidelines for the pharmacological treatment of migraine 81
A 67-Year-Old Woman With Recurrent Headache, Migratory Focal Symptoms, and Impaired Consciousness 81
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors 79
Migraine Treatment: Towards New Pharmacological Targets 77
Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study) 77
The relevance of cortical thickness in migraine sufferers and implications to therapy 74
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study 74
Safety of Onabotulinumtoxin-A for Chronic Migraine During Pregnancy and Breastfeeding: A Narrative Review 70
Monoclonal antibodies targeting the calcitonin gene-related peptide pathway improve the effectiveness of acute medication—a real-world study 69
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 69
Functional Changes of the Perigenual Part of the Anterior Cingulate Cortex after External Trigeminal Neurostimulation in Migraine Patients 68
Refractory migraine profile in CGRP-monoclonal antibodies scenario 68
Effectiveness and tolerability of atogepant as preventive treatment in resistant individuals with chronic migraine: Six-month real-world evidence 65
Sex differences in the clinical features of 2,841 patients with migraine: a post-hoc, multicenter, cross-sectional study 64
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men 61
Migraine Does Not Affect Pain Intensity Perception: A Cross-Sectional Study 61
Prospective memory is dysfunctional in migraine without aura 61
Pain-Related Brain Connectivity Changes in Migraine: A Narrative Review and Proof of Concept about Possible Novel Treatments Interference 61
OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study 58
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study 55
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study 53
Idiopathic hypertrophic pachymeningitis mimicking hemicrania continua: An unusual clinical case 52
Physiopathology of Migraine: What Have We Learned from Functional Imaging? 49
Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life Study 45
From mild cognitive impairment to normal cognition in Parkinson's disease: The role of brain network architecture 23
Subcortical microstructural impairment in amyotrophic lateral sclerosis: clinical correlates of neurite orientation dispersion and density imaging (NODDI) changes 22
Abnormal neurovascular coupling in the precuneus–posterior cingulate cortex may bridge simple and complex aura phenomena in the migraine brain 8
Totale 7.940
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.498
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022185 0 0 0 12 65 8 3 5 6 9 22 55
2022/2023339 40 12 6 18 43 13 0 15 174 2 13 3
2023/2024237 11 19 11 13 60 28 10 10 6 4 16 49
2024/2025817 1 20 12 21 154 76 104 63 140 83 91 52
2025/20265.290 167 211 182 174 534 2.983 311 224 242 136 84 42
2026/2027889 36 76 418 359 0 0 0 0 0 0 0 0
Totale 7.940